Biotech is a fast-moving sector that seems to be developing more quickly every year and at Glenmed, we make it our mission to stay abreast of emerging trends and developments.
5 Emerging Biotech Trends to Watch
Now that 2020 is well underway, we can expect to see a number of fascinating trends taking shape in the industry. Keep reading the blog as we discuss five biotech trends to look out for in 2020.
Emerging Biotech Trend #1: Advances in Gene & Cell Medicines
Complex drug platforms such as monoclonal antibodies, nucleic acid therapies and gene-based medicines, and other complex biotech platforms, all advanced rapidly last year, bringing attention and validation to these emerging technologies and delivering on the potential of some newer ones. During 2020, these technologies are likely to advance even further and at greater speed.
Emerging Biotech Trend #2: Personalised Medicine
It is becoming more and more possible and accepted for healthcare professionals to avoid the old method of offering blanket remedies to treat all patients for the same conditions. Instead, there is an increasing tendency to try to treat each patient uniquely according to their molecular make-up. Personalised medicine has slowly started building traction over the past few years and is sure to receive plenty of attention in the coming year.
Emerging Biotech Trend #3: Robot Surgeons
In the later part of 2019, advances in robotics started to lead to some truly astonishing developments in the surgical arena. Surgeons are beginning to find that robotic systems offer some incredible advantages. They provide precision, flexibility and control. They also make delicate, risky and complex procedures a great deal easier. This is a very capital-heavy area but the technology has advanced to a stage where it is sure to be very attractive to investors and we should, therefore, see it take tremendous strides during 2020.
Emerging Biotech Trend #4: Cross-species Transplantation
This was once the stuff of science fiction but it’s beginning to be taken very seriously. Regardless of the many ethical issues being raised around the matter, there is a lot of testing and research taking place. We’re not likely to see any actual major transplants during 2020, but expect the subject to be raised at industry events and online platforms a lot more.
Emerging Biotech Trend #5: Transformation after 2019’s Mergers & Acquisitions & Investment
From the business side, the sector saw considerable inflows of capital during 2019, as well as a series of game-changing mergers and acquisitions. Some leading biotech developers were bought out for princely sums by leading pharma companies and many smaller companies merged to form larger ones. Investors are watching the industry closely and are likely to inject a lot more funding into it during 2020.
Follow Glenmed for On-Trend Medical Tech Industry Insight
Glenmed specialises in the sale and servicing of industry-leading medical equipment across South Africa. Contact us for more information.